Since elevated expression of CHAF1A may cause accumulation of MTA via regulating amino acid metabolism, it is possible that purine analogue might be potential treatment option in MTAP deletion breast cancer patient with higher expression of CHAF1A. Here, CHAF1A is linked to breast carcinoma.